Skip to main content
OpenTrials
Completed

NCT Number: NCT03489642

Innovative Pulmonary Rehabilitation Telehealth Program for Improving COPD Patient Outcomes

Researchers want to learn more about telehealth pulmonary rehabilitation programs that help people with Chronic obstructive pulmonary disease (COPD) improve physical activity and quality of life.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

45 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Kansas Medical Center

Kansas City, Kansas, 66160, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hospital discharge diagnosis of COPD
  • Spirometry-confirmed evidence of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages I to IV
  • Access to internet connection and knowledge on use of web-based programs

Exclusion criteria

  • Persons with additional significant comorbidities including cancer, cardiac disease and physical impairments
  • Non-English speaking persons
  • The inability to provide an informed consent

Treatment and study plan

Telehealth Program

Behavioral

Telehealth program delivered remotely to study participants. Program developed by Cambium Technologies.

Primary outcomes

  1. Measure of physical activity

    Time frame: Change from Baseline to Week 12

    Changes will be measured using the Yale Physical Activity Survey (YPAS). The tool is composed of two sections - (a) amount of physical activity/exercise performed during a typical week in the past month and (b) activities performed in the past month. The final index score is the sum of five individual indices (vigorous, leisurely walking, moving, standing and sitting). Scores on the scale range from 0 to 137. The higher the score the more active a person.

Secondary outcomes

  1. Quality of Life

    Time frame: Change from Baseline to Week 12

    The COPD Assessment Test (CAT) will be used to measure the health status of the subjects. The test has eight questions. Each question has a range from 0-5. The total score for the test ranges from 0 to 40. The higher the score the more severe a person's COPD.

  2. Adherence to physical activity requirements

    Time frame: Week 12

    Patients receive an individualized exercise plan (minutes and days per week). Adherence to physical activity is assessed by the proportion of weeks subjects achieve their planned physical activity time.

Sponsors and collaborators

Lead sponsor

University of Kansas Medical Center

Other

Collaborators

  • American Association for Respiratory Care

Registry information

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Apr 5, 2018
Registry last updated
Mar 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.